What Is the Significance of Variant Histology in Urothelial Carcinoma?

Luchey, 2016, Change in management based on pathologic second opinion among bladder cancer patients presenting to a comprehensive cancer center: implications for clinical practice, Urology, 93, 130, 10.1016/j.urology.2016.01.048 Shah, 2013, Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital, Urol Oncol, 31, 1650, 10.1016/j.urolonc.2012.04.009 Linder, 2013, The impact of histological reclassification during pathology re-review—evidence of a Will Rogers effect in bladder cancer?, J Urol, 190, 1692, 10.1016/j.juro.2013.05.040 Moschini, 2017, Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study, Urol Oncol, 35, e1 Cai, 2014, Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens, Urology, 84, 1141, 10.1016/j.urology.2014.06.032 Abufaraj, 2018, Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder, World J Urol, 36, 231, 10.1007/s00345-017-2116-3 Warrick, 2019, Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants, Eur Urol, 75, 18, 10.1016/j.eururo.2018.09.003 Lagwinski, 2007, Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases, Am J Surg Pathol, 31, 1777, 10.1097/PAS.0b013e31805c9cd9 Grignon, 1991, Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases, Cancer, 67, 2165, 10.1002/1097-0142(19910415)67:8<2165::AID-CNCR2820670827>3.0.CO;2-M Erdemir, 2007, The effect of squamous and/or glandular differentiation on recurrence, progression and survival in urothelial carcinoma of bladder, Int Urol Nephrol, 39, 803, 10.1007/s11255-006-9151-0 Antunes, 2007, The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy, Int Braz J Urol, 33, 339, 10.1590/S1677-55382007000300006 Liu, 2017, Urothelial carcinoma with squamous differentiation is associated with high tumor stage and pelvic lymph-node metastasis, Cancer Control, 24, 78, 10.1177/107327481702400113 Mitra, 2014, Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis, Urol Oncol, 32, 117, 10.1016/j.urolonc.2012.08.017 Izard, 2015, Outcomes of squamous histology in bladder cancer: a population-based study, Urol Oncol, 33, e7 Zargar-Shostari, 2016, Clinical outcomes after neoadjuvant chemotherapy and radical cystectomy in the presence of urothelial carcinoma of the bladder with squamous or glandular differentiation, Clin Genitourin Cancer, 14, 82, 10.1016/j.clgc.2015.08.006 Minato, 2017, Squamous differentiation predicts poor response to cisplatin-based chemotherapy and unfavorable prognosis in urothelial carcinoma of the urinary bladder, Clin Genitourin Cancer, 15, 1063, 10.1016/j.clgc.2017.07.008 Scosyrev, 2011, Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710), BJU Int, 108, 693, 10.1111/j.1464-410X.2011.10582.x Krasnow, 2017, Clinical outcomes of patients with histologic variants of urothelial cancer treated with trimodality bladder-sparing therapy, Eur Urol, 72, 54, 10.1016/j.eururo.2016.12.002 Amin, 1994, Micropapillary variant of transitional cell carcinoma of the urinary bladder histologic pattern resembling ovarian papillary serous carcinoma, Am J Surg Pathol, 18, 1224, 10.1097/00000478-199412000-00005 Wang, 2012, Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis, World J Urol, 30, 801, 10.1007/s00345-012-0976-0 Fairey, 2014, Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy, Urol Oncol Semin Orig Investig, 32, 110, 10.1016/j.urolonc.2012.04.020 Mitra, 2019, Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: a multi-institutional investigation, Urol Oncol, 37, 48, 10.1016/j.urolonc.2018.10.013 Sui, 2016, Micropapillary bladder cancer: insights from the National Cancer Database, Bladder Cancer, 2, 415, 10.3233/BLC-160066 Ghoneim, 2011, Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder, Urology, 77, 867, 10.1016/j.urology.2010.11.043 Abufaraj, 2019, Micropapillary urothelial carcinoma of the bladder: a systematic review and meta-analysis of disease characteristics and treatment outcomes, Eur Urol, 75, 649, 10.1016/j.eururo.2018.11.052 Willis, 2015, Clinical outcomes of cT1 micropapillary bladder cancer, J Urol, 193, 1129, 10.1016/j.juro.2014.09.092 Kamat, 2007, Micropapillary bladder cancer, Cancer, 110, 62, 10.1002/cncr.22756 Spaliviero, 2014, Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder, J Urol, 192, 702, 10.1016/j.juro.2014.02.2565 Meeks, 2013, Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer, BJU Int, 111, E325, 10.1111/j.1464-410X.2012.11751.x Fernandez, 2017, Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer, BJU Int, 119, 684, 10.1111/bju.13689 Masson-Lecomte, 2015, Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy, World J Urol, 33, 1087, 10.1007/s00345-014-1387-1 Guo, 2016, Gene expression profile of the clinically aggressive micropapillary variant of bladder cancer, Eur Urol, 70, 611, 10.1016/j.eururo.2016.02.056 Young, 1991, Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases, Am J Clin Pathol, 96, 635, 10.1093/ajcp/96.5.635 Minghao, 2015, Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation, Am J Surg Pathol, 39, 127, 10.1097/PAS.0000000000000305 Lopez-Beltran, 2014, Microcystic urothelial carcinoma: morphology, immunohistochemistry and clinical behaviour, Histopathology, 64, 872, 10.1111/his.12345 Lopez-Beltran, 2014, Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder, Virchows Arch, 465, 199, 10.1007/s00428-014-1601-y Mally, 2017, Clinical outcomes of patients with T1 nested variant of urothelial carcinoma compared to pure urothelial carcinoma of the bladder, Clin Genitourin Cancer, 16, 23, 10.1016/j.clgc.2017.07.002 Linder, 2013, Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis, J Urol, 189, 1670, 10.1016/j.juro.2012.11.006 Williamson, 2011, Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features, Am J Surg Pathol, 35, 474, 10.1097/PAS.0b013e31820f709e Lopez-Beltran, 2001, Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases, Virchows Arch, 438, 552, 10.1007/s004280000378 Yang, 2017, Lymphoepithelioma-like, a variant of urothelial carcinoma of the urinary bladder: a case report and systematic review for optimal treatment modality for disease-free survival, BMC Urol, 17, 34, 10.1186/s12894-017-0224-4 Lopez-Beltran, 2009, Plasmacytoid urothelial carcinoma of the bladder, Hum Pathol, 40, 1023, 10.1016/j.humpath.2009.01.001 Fox, 2017, Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 49 cases, Am J Clin Pathol, 147, 500, 10.1093/ajcp/aqx029 Cockerill, 2017, Outcomes following radical cystectomy for plasmacytoid urothelial carcinoma: defining the need for improved local cancer control, Urology, 102, 143, 10.1016/j.urology.2016.09.053 Li, 2019, The impact of plasmacytoid variant histology on the survival of patients with urothelial carcinoma of bladder after radical cystectomy, Eur Urol Focus, 5, 104, 10.1016/j.euf.2017.06.013 Dayyani, 2013, Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis, J Urol, 189, 1656, 10.1016/j.juro.2012.11.084 Al-Ahmadie, 2016, Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer, Nat Genet, 48, 356, 10.1038/ng.3503 Ericson, 2019, Plasmacytoid variant urothelial carcinoma: clinicopathologic outcomes and experience with neoadjuvant chemotherapy, J Clin Oncol, 37, 483, 10.1200/JCO.2019.37.7_suppl.483 Diamantopoulos, 2019, Patient characteristics, treatment patterns, outcomes and prognostic factors in plasmacytoid urothelial carcinoma, J Clin Oncol, 37, 10.1200/JCO.2019.37.15_suppl.e16007 Lopez-Beltran, 1988, Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases, J Urol, 159, 1497, 10.1097/00005392-199805000-00023 Sanfrancesco, 2016, Sarcomatoid urothelial carcinoma of the bladder: analysis of 28 cases with emphasis on clinicopathologic features and markers of epithelial–mesenchymal transition, Arch Pathol Lab Med, 140, 543, 10.5858/arpa.2015-0085-OA Cheng, 2011, Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation, Am J Surg Pathol, 35, e34, 10.1097/PAS.0b013e3182159dec Wright, 2007, Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder, J Urol, 178, 2302, 10.1016/j.juro.2007.08.038 Sui, 2017, Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer, World J Urol, 7, 1055, 10.1007/s00345-016-1962-8 Vetterlein, 2017, Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology, Cancer, 123, 4346, 10.1002/cncr.30907 Berg, 2019, Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: does histologic subtype matter?, Cancer, 125, 1449, 10.1002/cncr.31952 Lopez‐Beltran, 2004, Further commentary: tumours of the urinary system, 90 Oliva, 2002, Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of Mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems, Am J Surg Pathol, 26, 190, 10.1097/00000478-200202000-00005 Mai, 2017, Clear cell urothelial carcinoma: a study of 10 cases and meta-analysis of the entity. Evidence of mesonephric differentiation, Int J Surg Pathol, 25, 18, 10.1177/1066896916660195 Mukesh, 2009, Small cell carcinoma of the urinary bladder: a 15 year retrospective review of treatment and survival in the Anglian Cancer Network, BJU Int, 103, 747, 10.1111/j.1464-410X.2008.08241.x Wang, 2018, Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases, Hum Pathol, 79, 57, 10.1016/j.humpath.2018.05.005 Preimer, 2018, Small-cell carcinomas of the urinary bladder and prostate: TERT promoter mutations status differentiates sites of malignancy and provides evidence of common clonality between small-cell carcinoma of the urinary bladder and urothelial carcinoma, Eur Urol Focus, 4, 880, 10.1016/j.euf.2017.03.007 Siefker-Radtke, 2009, Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small cell urothelial cancer, J Clin Oncol, 27, 2592, 10.1200/JCO.2008.19.0256 Lynch, 2013, Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Centre, Eur Urol, 64, 307, 10.1016/j.eururo.2012.04.020 Abol-Enein, 2007, Non-urothelial cancer of the bladder, Urology, 69, 93, 10.1016/j.urology.2006.08.1107 Felix, 2008, The changing patterns of bladder cancer in Egypt over the past 26 years, Cancer Causes Control, 19, 421, 10.1007/s10552-007-9104-7 Matulay, 2019, The impact of squamous histology on survival in patients with muscle-invasive bladder cancer, Urol Oncol, 37, e17 Kassouf, 2007, Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of the University of Texas MD Anderson Cancer Centre experience, Cancer, 110, 764, 10.1002/cncr.22853 Abdel-Rahman, 2017, Squamous cell carcinoma of the bladder: a SEER database analysis, Clin Genitourin Cancer, 15, e463, 10.1016/j.clgc.2016.10.007 Fischer-Valuck, 2018, A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database, Clin Transl Radiat Oncol, 15, 38, 10.1016/j.ctro.2018.12.001 Dotson, 2019, Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy, Int J Clin Oncol, 24, 706, 10.1007/s10147-019-01409-x Natale, 2019, Reviewing the demographic, prognostic and treatment factor of primary adenocarcinoma of the bladder: a SEER population based study, Clin Genitourin Cancer, 10.1016/j.clgc.2019.06.010 Zaffuto, 2017, Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA, Int J Urol, 24, 117, 10.1111/iju.13261 Lughezzani, 2010, Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality, Urology, 75, 376, 10.1016/j.urology.2009.10.018 Dutta, 2016, Effect of tumor location on survival in urinary bladder adenocarcinoma: a population-based analysis, Urol Oncol, 34, e1 Zaghloul, 2006, Long term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients, Urol Oncol, 24, 13, 10.1016/j.urolonc.2005.05.027 Davaro, 2019, Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database, World J Urol, 37, 497, 10.1007/s00345-018-2411-7